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Abstract 
Background: Glycolic acid (GA) is a two-carbon hydroxyacid with applications in the cosmetic, textile, and medical 
industry. Microbial GA production from all sugars can be achieved by engineering the natural glyoxylate shunt. The 
synthetic (d)-xylulose-1 phosphate (X1P) pathway provides a complementary route to produce GA from (d)-xylose. 
The simultaneous operation of the X1P and glyoxylate pathways increases the theoretical GA yield from xylose by 
20 %, which may strongly improve GA production from hemicellulosic hydrolysates.
Results: We herein describe the construction of an E. coli strain that produces GA via the glyoxylate pathway at a 
yield of 0.31 , 0.29 , and 0.37 g/g from glucose, xylose, or a mixture of glucose and xylose (mass ratio: 33:66 %), respec-
tively. When the X1P pathway operates in addition to the glyoxylate pathway, the GA yields on the three substrates 
are, respectively, 0.39 , 0.43 , and 0.47 g/g. Upon constitutive expression of the sugar permease GalP, the GA yield of 
the strain which simultaneously operates the glyoxylate and X1P pathways further increases to 0.63 g/g when grow-
ing on the glucose/xylose mixture. Under these conditions, the GA yield on the xylose fraction of the sugar mixture 
reaches 0.75 g/g, which is the highest yield reported to date.
Conclusions: These results demonstrate that the synthetic X1P pathway has a very strong potential to improve GA 
production from xylose-rich hemicellulosic hydrolysates.
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Background
Glycolic acid (GA) is a two-carbon hydroxycarboxylic 
acid of considerable industrial interest. It is used as a 
tanning, peeling, and cleaning agent in the cosmetic and 
textile industry [1–3]. GA can be polymerized to produce 
biodegradable poly-glycolic acid (PGA) which is used as 
a packaging material for food and beverages [4]. Co-pol-
ymers of PGA and poly-lactic acid are used as absorbable 
suture and implant matrices [5, 6]. The market volume of 
GA continues to grow substantially and was reported to 
be 40 kilotons in 2014 [7].
At the industrial scale, GA is produced from fossil 
resources by treating formaldehyde with carbon monoxide 
[8], or by treating chloroacetic acid with sodium hydrox-
ide [2]. Growing concerns about the future availability 
of fossil resources and the environmental impact of their 
use [9, 10] have increased the interest in microbial pro-
duction of GA. Until recently, sugar-based biosynthesis of 
GA was exclusively achieved by engineering the natural 
glyoxylate pathways in bacteria or yeast. GA production 
was accomplished by overexpressing isocitrate lyase and 
glyoxylate reductase enzymes, by deleting glyoxylate con-
suming reactions, and in some cases by attenuating isoci-
trate dehydrogenase activity ([11–15] and Table  1). The 
best results were obtained with an optimized Escherichia 
coli strain which produced 56 g/l GA at a yield of 0.52 g/g 
in a fed-batch reactor using glucose as the carbon source 
([11], Table 1).
Glycolic acid production through the glyoxylate path-
way inevitably requires the decarboxylation of pyruvate 
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Table 1 Production of glycolic acid (GA) by different engineered microorganisms
* Estimated yield on the xylose fraction of the sugar mixture
Microorganism Strain characteristics Experimental conditions Final GA conc. [g/L] GA yield [g/g] References
Escherichia coli Engineered glyoxylate shunt
Reduced expression of icd by weak promoter
Deletion of aceB, gcl, glcDEFGB, aldA, iclR, 
edd-eda, poxB, ackA + pta, ldhA, mgsA, arcA
Overexpression of ghrA and aceA
Shake flask




Reduced expression of icd by weak promoter
Deletion of aceB, gcl, glcDEFGB, aldA, iclR, 
edd-eda, poxB, ackA + pta, arcA
Overexpression of ghrA and aceA
Fed-batch fermentation





Deletion of MLS1, IDP2
Overexpression of GLYR1
Fed batch fermentation
Mineral medium with xylose 










CGXII minimal medium (10.8 g/l 
glucose + 10.6 g/l acetate)
5.30 0.18 [15]
E. coli Synthetic (d)-xylulose-1P pathway
Expression of khkC, aldoB, aldA
Deletion of xylB, glcD
Shake flask
Mineral medium + 10 g/l 
xylose
4.30 0.46 [16]
E. coli Engineered glyoxylate shunt
Deletion of aceB, glcB
Overexpression of ghrA, aceA, aceK
Evolved strain
Shake flask








Mineral medium + glucose
56.44 0.52
E. coli Synthetic xylulose epimerase pathway
Expression of Pc-dte, fucK, fucA, aldA
Deletion of glcD, xylB
Test tube




Mineral medium + >100 g/l 
xylose
44.00 0.44
Synthetic xylulose epimerase 
pathway+engineered glyoxylate shunt
Expression of Pc-dte, fucK, fucA, aldA
Deletion of glcD, xylB, aceB, glcB, gcl
Overexpression of ghrA, aceA and aceK
Batch bioreactor
Mineral medium + 65 g/l 
xylose
40.00 0.63
E. coli Engineered glyoxylate shunt Shake flask
Mineral medium + 10 g/l 
glucose (2 g/l tryptone, 1 g/l 
yeast extract)
2.64 0.31 This study
Synthetic (d)-xylulose-1P pathway + engi-
neered glyoxylate shunt
Expression of khkC, aldoB, aldA
Deletion of aceB, gcl, glcDEFGB, iclR, edd-eda, 
arcA, icd, xylB
Overexpression of ghrA and aceA
Shake flask
Mineral medium + 10 g/l 
xylose (2 g/l tryptone, 1 g/l 
yeast extract)
2.24 0.43
Synthetic (d)-xylulose-1P pathway + engi-
neered glyoxylate shunt
Expression of khkC, aldoB, aldA
Deletion of aceB, gcl, glcDEFGB, iclR, edd-eda, 
arcA, icd, xylB
Overexpression of ghrA and aceA
galPexpressed from constitutive promoter 
proD
Shake flask
Mineral medium + 2,5 g/l 
glucose and 5 g/l xylose (2 g/l 
tryptone, 1 g/l yeast extract)
3.73 0.63 (0.75)*
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to provide the Krebs cycle substrate acetyl-CoA. Thus, 
the maximum yields for the glyoxylate pathway-depend-
ent biosynthesis of GA from glucose or xylose are lim-
ited to 2 mol/mol (0.84 g/g) and 1.66 mol/mol (0.84 g/g), 
respectively. Recently, two synthetic pathways have been 
proposed that provide an improved stoichiometry for 
the synthesis of GA from (d)-xylose thereby increasing 
the maximum GA yield to 2 mol/mol (1 g/g). Both path-
ways employ a carbon-conserving asymmetric aldolase 
cleavage of a C5 sugar that produces the C2 compound 
glycolaldehyde which is a direct precursor of GA, and 
the C3 compound DHAP [14, 16]. Our group has devel-
oped the reaction sequence that employs xylulose-1 
kinase, xylulose-1-phosphate (X1P) aldolase, and glyco-
laldehyde dehydrogenase activities [16]. These activities 
were provided by expressing the genes encoding human 
ketohexokinase C (khkC), aldolase B (aldoB), and endog-
enous aldehyde dehydrogenase (aldA), respectively. We 
have termed this reaction sequence (d)-xylulose-1-phos-
phate pathway, and demonstrated the production of 
GA from pure xylose at a yield of 0.46  g/g correspond-
ing to 94 % of the maximum yield of this pathway ([16], 
Table  1). Pereira and colleagues (2016) used a (d)-xylu-
lose epimerase to transform (d)-xylulose into (d)-ribu-
lose which was further converted to glycolaldehyde and 
DHAP by the consecutive action of (d)-ribulose-1 kinase 
and (d)-ribulose-1 aldolase. They demonstrated GA pro-
duction from pure (d)-xylose during simultaneous opera-
tion of the glyoxylate and xylulose epimerase pathways, 
and achieved a GA yield of 0.63 g/g ([14], Table 1).
However, the utilization of pure xylose is an unrealistic 
scenario for the industrial production of GA. Although 
(d)-xylose can account for up to 80 % of the sugar frac-
tion of hemicellulosic hydrolysates, the glucose content 
in these feedstocks is still substantial and reaches up 
to 35  % depending on raw material and hydrolyzation 
method [17]. Therefore, we investigated the potential of 
the synthetic X1P pathway to increase GA production 
on a synthetic sugar mixture that contained xylose and 
glucose at a ratio of 66 and 33  % which we considered 
representative for a large panel of hemicellulosic hydro-
lysates. We engineered an E. coli strain to facilitate GA 
production through the glyoxylate pathway alone or in 
combination with the X1P pathway (Fig.  1). When GA 
was exclusively synthesized via the glyoxylate shunt, the 
strain produced GA at a yield of 0.37 g/g from the sugar 
mixture. Upon the additional operation of the X1P path-
way, the GA yield increased to 0.47  g/g, and reached 
0.63 g/g when the broad-range sugar permease GalP was 
additionally overexpressed from a constitutive promoter. 
Under these conditions, the GA yield on the xylose frac-
tion of the sugar mixture reached 0.75 g/g, which corre-
sponds to 75 % of the theoretical maximum yield.
Methods
Strains and plasmid construction
Escherichia coli K-12 MG1655 (ATCC 47076) was used 
as the parental strain for all strain constructions in this 
study. The constructed strains are listed in Table 2. Gene 
deletions were introduced either by homologous recom-
bination using the λ Red recombinase system [18], in the 
case of glcDEFGB, edd-eda, and iclR, or by the phage 
transduction method [19], in the case of aceB, gcl, arcA, 
icd and xylB. Gene deletion cassettes were amplified 
from pKD3 or pKD4 plasmids (Table 3) that have a chlo-
ramphenicol or a kanamycin resistance marker, respec-
tively, using primers with 50 bp homologies to the target 
locus. The deletion cassettes were purified using a PCR 
purification kit (Thermo Scientific) and transformed into 
the target strains using a standard protocol [20]. Cell 
lysates for phage transductions were prepared from sin-
gle-gene deletion mutants of the Keio strain collection 
[21].
Expression of galP was rendered constitutive by replac-
ing the natural chromosomal 5′-UTR of galP by the 
synthetic constitutive promoter proD [22]. The proD 
sequence was synthesized by Eurofins™. The kanamycine 
resistance cassette of the pKD4 plasmid and the syn-
thetic promoter were individually amplified by Phusion 
polymerase (Biolabs) and fused by overlap extension PCR 
adding 50  bp flanking sequences that were homologous 
to the target locus. The resulting DNA fragment was 
used to replace the natural galP promoter by homologous 
recombination [18].
Plasmid constructions: aceA and ghrA genes were PCR 
amplified from Escherichia coli K-12 MG1655 genomic 
DNA using Phusion polymerase (Biolabs) with prim-
ers listed in Table 4. The DNA fragments were purified 
using a PCR purification kit (Thermo Scientific). The 
medium-copy pACT3 plasmid [23] was linearized with 
BamHI and HindIII (BioLabs), and the DNA fragments 
and the linearized vector were recombined using the 
In-Fusion® HD Cloning Kit (Clontech). The resulting 
plasmid was named pGS. The construction of plasmid 
pXlP, which expresses the genes encoding for aldehyde 
dehydrogenase from E. coli, and human ketohexokinase 
C and aldolase B, respectively, was described previ-
ously [16]. The plasmids were transformed into different 
host strains alone or in combination. Strains and prim-
ers used in these studies are listed in Tables  2 and 3, 
respectively.
Media and cultivation conditions
Luria–Bertani (LB) medium [24] was used for prepara-
tions of precultures and genetic manipulations. Growth 
and production cultures were carried out in M9 mini-
mal medium which contained (d)-glucose, (d)-xylose or 
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a mixture of (d)-glucose/(d)-xylose. Carbon source con-
centrations of M9 minimal medium are indicated in the 
text. M9 minimal medium contained 18  g/l Na2HPO4 · 
12 H2O, 3 g/l KH2PO4, 0.5 g/l NaCl, 2 g/l NH4Cl, 0.5 g/l 
MgSO4 · 7 H2O, 0.015 g/l CaCl2 · 2 H2O, 0.010 g/l FeCl3, 
0.006  g/l Thiamine HCl, 0.4  mg/l NaEDTA · 2 H2O, 
1.8  mg/LCoCl2 · 6 H2O, 1.8  mg/l ZnCl2SO4 · 7 H2O, 
0.4 mg/L Na2MoO4 · 2 H2O, 0.1 mg/L H3BO3, 1.2 mg/L 
MnSO4 · H2O, 1.2 mg/L CuCl2 · 2 H2O. The medium was 
buffered at pH 7 by addition of 20 g/l MOPS (3-(N-mor-
pholino) propanesulfonic acid) and sterilized by filtration 
(Merck Millipore ExpressPlus). 0.2 % ‘w/v’ tryptone and 
0.1 % ‘w/v’ yeast extract were added to the M9 minimal 
medium from 5× sterile stock solutions to grow strains 
with an icd deletion. When required, ampicillin, kanamy-
cin and chloramphenicol were added to the media at a 
concentration of 100, 50, and 25 µg/mL, respectively. All 
chemicals were purchased from Sigma-Aldrich.
Pre-cultures were grown overnight at 200 rpm shaking 
speed in 50 mL test tubes (BD Falcon) with 10 mL of M9 
minimal medium supplemented with the carbon sources 
used in the production cultures. For inoculation of the 
cultures into 250 mL baffled shake flask, precultures were 
harvested by centrifugation for 5  min (4000×g, Allegra 
21-R, Beckman-Coulter) and washed once with ster-
ile distilled water. Cells were inoculated at OD600  ~  0.1 
Table 2 Escherichia coli strains used in this study
Strain name Genotype Reference
MG1655 F− λ−ilvG-rfb-50 rph-1 ATCC 47076
NEB5-α fhuA2 Δ(argF-lacZ)U169 phoA glnV44 Φ80Δ (lacZ)M15 gyrA96 recA1 relA1 endA1 thi-1 hsdR17 NEB
JW3536-2 F-, Δ(araD-araB)567, ΔlacZ4787(::rrnB-3), λ-, rph-1, Δ(rhaD-rhaB)568, hsdR514 ΔxylB747::kan [21]
JW3974-1 F-, Δ(araD-araB)567, ΔlacZ4787(::rrnB-3), λ-, rph-1, Δ(rhaD-rhaB)568, hsdR514 ΔaceB781::kan, [21]
JW0495-1 F-, Δ(araD-araB)567, ΔlacZ4787(::rrnB-3), λ-, rph-1, Δ(rhaD-rhaB)568, hsdR514 Δgcl-790::kan [21]
JW4364-1 F-, Δ(araD-araB)567, ΔlacZ4787(::rrnB-3), λ-, rph-1, Δ(rhaD-rhaB)568, hsdR514 ΔarcA726::kan [21]
JW1122-2 F-, Δ(araD-araB)567, ΔlacZ4787(::rrnB-3), λ-, rph-1, Δ(rhaD-rhaB)568, hsdR514 Δicd-724::kan [21]
Pen804 ΔaceB ΔglcDEFGB Δgcl Δedd-eda This study
Pen807 Pen804 containing pGS This study
Pen847 Pen804 ΔiclR::FRT pGS This study
Pen851 Pen847 ΔarcA::FRT pGS This study
Pen1046 Pen851 Δicd::FRT This study
Pen1042 Pen1046 containing pGS This study
Pen1043 Pen1046 containing pX1P This study
Pen1044 Pen1042 containing pX1P This study
Pen1099 Pen1046 galPproD containing pGS and pX1P This study
Pen1100 Pen1046 containing pACT3-empty This study
Pen880 ΔaceB ΔglcDEFGB Δgcl Δedd-eda ΔiclR ΔarcA Δicd ΔxylB This study
Pen1048 Pen880 containing pX1P This study
Pen905 Pen1048 containing pGS This study
Pen979 Pen880 galPproD containing pGS and pX1P This study
Table 3 Plasmids used in this study
Name Relevant characteristics Reference
pCP20 ori pSC101, AmpR, plasmid expressing Flp recombinase to remove Kan cassette [42]
pKD46 ori oriR101 w/repA101ts, AmpR, plasmid expressing λ Red recombinase genes [18]
pKD3 ori R6 Kγ, CmR, source for cat cassette [18]
pKD4 ori R6 Kγ, KanR, source for kan cassette [18]
pACT3 ori p15A, CmR [23]
pEXT20 ori colE1, AmpR [23]
pGS pACT3 derivative carrying ghrA and aceA genes from E. coli This study
pX1P pEXT20 derivative carrying human genes khk-c and codon optimized aldoB, and aldA from E. coli [16]
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into 25  mL fresh M9 minimal medium containing an 
appropriate concentration of carbon source (see text) 
and cultivated in 250 mL baffled flask on a rotary shaker 
(Infors HT) running at 200  rpm. Growth was followed 
by measure of optical density at 600  nm (OD600) using 
a Biochrom Libra S11 spectrophotometer. Expression of 
the GA-producing pathways was induced by addition of 
isopropyl β-d-1-thiogalactopyranoside (IPTG) when the 
OD600 reached ~0.8. All cultivations were carried out at 
30 °C.
Table 4 Primers used in this study
Restriction sites are italicized and the start codons are shown in bold–italics
Primer Sequence 5′→ 3′
Gene deletions by homologous recombination
 glcDEFGB_fw GCGTCTTGATGGCGCTTTACCCGATGTCGACCGCACATCGGTACTGATGGCACTGCGTGAGCATGTCCCT 
GGACTTGAGATCGTGTAGGCTGGAGCTGCTTC
 glcDEFGB_rev CGCGTAAACGCCAGGCGTGTAATAACGGTTCGGTATAGCCGTTTGGCTGTTTCACGCCGAGGAAGATTA 
AATCGCTGGCCATATGAATATCCTCCTTAG
 edd eda_fw CGCGCGAGACTCGCTCTGCTTATCTCGCCCGGATAGAACAAGCGAAAACTTCGACCGTTCATC 
GTTCGCAGTTGGCATGCGGGTGTAGGCTGGAGCTGCTTC
 edd eda_rev GCTTAGCGCCTTCTACAGCTTCACGCGCCAGCTTAGTAATGCGGTCGTAATCGCCCGCTTCCAGCGCATCTG 
CCGGAACCCATATGAATATCCTCCTTAG
 iclR_fw CGCACCCATTCCCGCGAAACGCGGCAGAAAACCCGCCGTTGCCACCGCACCAGCGACTGGACAGGTTC 
AGTCTTTAACGCGTGTAGGCTGGAGCTGCTTCG
 iclR_rev GCGCATTCCACCGTACGCCAGCGTCACTTCCTTCGCCGCTTTAATCACCATCGCGCCAAACTCGGTCAC 
GCGGTCATCGGCATATGAATATCCTCCTTAG
Construction of synthetic galP promoter
 galP-KAN-fw CCGCCCGCA CAATAACATCATTCTTCCTG ATCACGTTTCACCGCAGATTAGTGTAGGCTGGAGCTGCTTC
 galP-KAN-rev GATAGGGACGACGTGGTGTTAGCTGTGCATATGAATATCCTCCTTAG
 galP-prom-fw CACAGCTAACACCACGTCGT





















Cloning of ghrA and aceA
 pACT ycdW-Fw GAGCTCGGTACCCGGGGATCCAGGAGGCACACGATGGATATCATCTTTTATCACC
 Operon ycdW-Rev TCATACGGTTCCTCCTTTAGTAGCCGCGTGCGCGGTCGACTT
 Operon aceA-Fw GCACGCGGCTACTAAAGGAGGAACCGTATGAAAACCCGTACACAACAAATTG
 pACT aceA-Rev CTCATCCGCCAAAACAGAAGCTTTTAGAACTGCGATTCTTCAGTGGA
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Analytical methods for extracellular metabolites 
quantifications
Samples for metabolite quantification were regularly 
withdrawn from the cultures, centrifuged at 13,000 rpm 
for 5 min in a bench-top centrifuge (Eppendorf 5415D), 
filtered through a 0.2-µm syringe filter, and stored at 
−20  °C until further analysis. Quantification of sugars 
and organic acids was carried out by high performance 
liquid chromatography (HPLC) on an Ultimate 3000 sys-
tem (Dionex, Sunnyvale, USA). The HPLC system was 
equipped with a cation-exchange column (Aminex HPX-
87H— 300  ×  7.8  mm, 9  µm, Biorad), an autosampler 
(WPS-3000RS, Dionex), a RI detector (RID 10A, Shi-
madzu), and an UV/VIS detector (SPD-20A, Shimadzu). 
The mobile phase was 1.25 mM H2SO4 at a flow rate of 
0.5 mL/min. Column temperature was held at 35 °C.
Results and discussion
Metabolic engineering for optimizing glycolic acid 
production via the glyoxylate shunt
We first set out to engineer an E. coli strain for produc-
tion of GA via the glyoxylate shunt by inactivating all 
annotated reactions that consume glyoxylic acid, i.e., 
malate synthase, encoded by aceB and glcB [25, 26], 
glyoxylate carboligase, encoded by gcl [27], and 2-oxo-
4-hydroxyglutarate aldolase, encoded by eda [28, 29]. Re-
oxidation of GA was prevented by deleting the glycolate 
oxidase-encoding glcDEFG operon [30]. Derepression of 
the glyoxylic acid-producing isocitrate lyase, AceA, was 
brought about by deletion of the transcriptional repres-
sor, IclR [31, 32]. The strain which carried these deletions 
was transformed with plasmid pGS which expressed 
the isocitrate lyase and glyoxylate reductase encoding 
genes aceA and ghrA, respectively [33, 34] (Fig.  1). The 
resulting strain Pen847 produced 0.69  ±  0.23  g/l GA 
(0.06 g/g yield) when cultivated on mineral medium sup-
plemented with 10 g/l glucose (Table 5). The additional 
deletion of the transcriptional repressor of Krebs cycle 
genes, ArcA [35] in strain Pen851 only slightly increased 
GA production to 0.80 ±  0.15  g/l (0.07  g/g yield). The 
isocitrate lyase from E. coli, AceA, has a low affinity for 
isocitrate (Km = 0.89 mM) when compared to isocitrate 
dehydrogenase (Icd, Km = 0.029 mM) [36]. Thus, it was 
possible that GA production was low because AceA was 
outcompeted by Icd. In agreement with this idea, the 
deletion of Icd in strain Pen1042 resulted in significant 
production of GA, which accumulated to 2.64 ± 0.77 g/l 
corresponding to a yield of 0.31 g/g (Table 5). It is of note 
that the strains that carried the Δicd deletion were una-
ble to grow on mineral medium. To restore their growth, 
the cultivation medium was supplemented with yeast 
extract and tryptone. However, no detectable quantities 
of GA were produced from these supplements when no 
additional sugar (glucose or xylose) was provided (not 
shown). Significant production of GA required the over-
expression of GhrA and/or AceA from plasmid pGS, 
since strain Pen1100 which contained the empty pACT3 
plasmid did not produce any GA but accumulated nearly 
5  g/l acetate (Table  5). These results are in qualitative 
agreement with the work of Dischert [12] and Deng 
[11] who reported that a strong decrease of Icd activity, 
brought about by decreasing the expression of icd or by 
overexpressing the Icd-inactivating protein kinase AceK, 
respectively, was required to achieve significant GA 
production.
Co‑function of glyoxylate and xylulose‑1P pathways does 
not increase GA production on pure d‑xylose
Since we wanted to quantify the increase of GA produc-
tion from xylose that was due to the additional operation 
of the synthetic X1P pathway (see below), we first had 
to verify that expression of the enzymes that build up 
the X1P pathway have no unspecific side effects on GA 
production via the glyoxylate shunt. We therefore trans-
formed plasmid pX1P, which carries the genes khkC, 
aldoB, and aldA genes that encode the X1P pathway 
enzymes, into the strains whose genotype was optimized 
for glyoxylate-dependent GA production and character-
ized them during growth on glucose. We found that the 
strains Pen1043 and Pen1048 which expressed pX1P 
alone produced no GA, thus confirming that pGS that 
bears GhrA and AceA genes was required for GA pro-
duction through the glyoxylate shunt (Table  5). Strains 
Pen1044 and Pen905, which expressed both pGS and 
pX1P, produced GA at yields that were not statistically 
different from Pen1042 (Table  5). These results showed 
that the presence of the enzymes that build-up the X1P 
pathway does not significantly impact on GA produc-
tion through the glyoxylate shunt. Thus, when studying 
GA production from xylose, which can be converted to 
GA through the glyoxylate and/or the X1P pathway, the 
observed differences could be clearly attributed to the 
function of the individual pathways, ruling out potential 
non-specific side effects of the X1P pathway enzymes.
After having demonstrated glyoxylate shunt-depend-
ent GA production from glucose, we investigated GA 
production from xylose during simultaneous or indi-
vidual function of the glyoxylate and X1P pathways. 
Strain Pen1042 assimilated xylose via the natural pen-
tose phosphate pathway and produced GA through the 
glyoxylate shunt at a yield of 0.29 g/g (Table 6). Absence 
of GA production in the isogenic strain Pen1100, which 
contained the empty pACT3 plasmid instead of pGS, 
confirmed that overexpression of GhrA and/or AceA 
was also required for GA production on xylose-contain-
ing medium. To enable xylose assimilation through the 
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synthetic X1P pathway, the xylulose-5 kinase encod-
ing gene xylB was additionally deleted in the host strain 
which carried the engineered glyoxylate shunt. To restore 
growth on xylose, this strain was transformed with plas-
mid pX1P, and the resulting strain Pen1048 produced GA 
with a yield of 0.45 g/g, which corresponds to 89 % of the 
maximum yield (0.5  g/g) of the synthetic pathway. The 
GA yield of Pen1048 was 55 % higher than for Pen1042, 
indicating that GA production by the X1P pathway was 
more efficient than by the glyoxylate shunt. Contrary to 
our expectation, the simultaneous operation of the gly-
oxylate and X1P pathways in strain Pen905 did not result 
in a further increase of the GA yield which only reached 
0.43 g/g (Table 6). The reason for the failure to increase 
GA production by the co-function of both pathways dur-
ing growth on pure xylose is not entirely clear. We specu-
late that the metabolic burden due to the propagation of 
two plasmids and the severely reduced Krebs cycle func-
tion due to the deletion of icd were responsible for the 
very strong growth retardation of this strain (not shown) 
which ultimately impaired efficient GA production under 
these conditions. 
Simultaneous function of the glyoxylate 
and (d)‑xylulose‑1P glycolic acid pathways strongly 
increases product yield during co‑assimilation of glucose 
and xylose
The development of the synthetic X1P pathway and its 
simultaneous operation with the engineered glyoxy-
late shunt was meant to increase GA production from 
xylose-rich second generation feedstocks. Hemicellu-
losic hydrolysates typically contain 50–75  % xylose and 
15–40 % glucose together with smaller amounts of other 
sugars [17, 37]. In order to test whether GA production 
from these feedstocks could be increased by the simul-
taneous operation of the X1P and glyoxylate pathways, 
we chose to incubate our strains on a sugar mixture that 
contained 2.5  g/l glucose and 5  g/l xylose, which corre-
sponds to a mass ratio (33  %/66  %) that is representa-
tive for hemicellulosic hydrolysates. Strains Pen1042 
and Pen1044, which produce GA exclusively through the 
glyoxylate shunt, exhibited very similar GA yields of 0.37 
and 0.42 g/g, respectively, that were calculated based on 
the total amounts of consumed sugars (glucose+xylose, 
Table 7). Due to the sequential utilization of glucose and 
xylose by these strains (not shown), the GA yield on the 
corresponding sugar fractions could be calculated indi-
vidually. Interestingly, the GA yield on the xylose frac-
tion of the sugar mixture (0.47  g/g) was significantly 
higher than when these strains were incubated on pure 
xylose (0.29  g/g). The reason for this behavior is not 
entirely clear, but it appears likely that more xylose could 
be converted to GA due to the very residual growth dur-
ing utilization of the xylose fraction of the sugar mixture 
(compare to Fig. 2). 
Strain Pen905, which operates both the glyoxylate and 
the X1P pathway, produced GA with a yield of 0.47 g/g. 
Thus, the simultaneous operation of the X1P and glyoxy-
late pathways conferred a ~27 % increased GA yield when 
compared to the exclusive operation of the glyoxylate 
pathway. The GA yield on the xylose fraction was 0.6 g/g 
(Table 7) which is significantly higher than the GA yield 
which was reached by this strain on pure xylose (0.43 g/g, 
Table  6). The simplest way to explain this difference is 
that the GA-producing pathways could be appropriately 
expressed in the sugar mixture during the exponential 
growth phase on glucose, whereas GA production on 
pure xylose remained comparatively low because growth 
Table 5 Production of glycolic acid by different E. coli strains in medium containing glucose as carbon source
All strains carried the deletions ∆aceB ∆glcDEFGB ∆gcl ∆edd-eda ∆iclR. Additional deletions are indicated in the table. Initial glucose concentration was 10 g/l. The 
mineral medium was supplemented with 2 g/l tryptone and 1 g/l yeast extract
a pGS expresses glyoxylate reductase and isocitrate lyase, encoded by ghrA and aceA. pX1P carries (d)-xylulose-1 kinase, (d)-xylulose-1 aldolase and glycolaldehyde 
dehydrogenase, encoded by khkC, aldoB and aldA, respectively. pACT3 is the empty plasmid. Results are presented as mean ± STDV calculated from at least two 
replicate experiments
Strain name Additional deletions Plasmidsa Biomass Glycolic acid Acetate
Yield [g/g] Final conc. [g/l] Yield [g/g] Final conc. [g/l] Yield [g/g]
Pen847 pGS 0.30 ± 0.03 0.69 ± 0.23 0.06 ± 0.01 0.06 ± 0.08 0.01 ± 0.01
Pen851 ΔarcA pGS 0.30 ± 0.01 0.80 ± 0.15 0.07 ± 0.00 0.00 ± 0.00 0.00 ± 0.00
Pen1042 ΔarcA Δicd pGS 0.15 ± 0.02 2.64 ± 0.77 0.31 ± 0.05 0.93 ± 0.58 0.12 ± 0.08
Pen1100 ΔarcA Δicd pACT3 0.08 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 4.80 ± 0.04 0.55 ± 0.00
Pen1043 ΔarcA Δicd pX1P 0.12 ± 0.03 0.00 ± 0.00 0.00 ± 0.00 3.11 ± 0.96 0.47 ± 0.05
Pen1044 ΔarcA Δicd pGS + pX1P 0.17 ± 0.03 3.02 ± 0.27 0.37 ± 0.03 0.22 ± 0.19 0.03 ± 0.02
Pen1048 ΔarcA Δicd ΔxylB pX1P 0.09 ± 0.01 0.00 ± 0.00 0.00 ± 0.00 4.44 ± 0.13 0.61 ± 0.01
Pen905 ΔarcA Δicd ΔxylB pGS + pX1P 0.16 ± 0.03 2.96 ± 0.25 0.39 ± 0.05 0.00 ± 0.00 0.00 ± 0.00








































Fig. 1 Synthetic (blue) (D)-xylulose-1 phosphate (X1P) and natural (black) pathways for the production of glycolic acid from (d)-xylose and (d)-
glucose. Relevant genes are depicted in blue next to the reactions that they encode. Bold black arrows indicate overexpression of the activity. DHAP 
dihydroxyacetone phosphate, GAP glyceraldehyde-3P, α-KG  α-ketoglutarate)
Table 6 Production of glycolic acid by different E. coli strains in medium containing xylose as carbon source
All strains carried the deletions ∆aceB ∆glcDEFGB ∆gcl ∆edd-eda ΔiclR ΔarcA Δicd. Additional deletions are indicated in the table. Initial xylose concentration was 10 g/l. 
The mineral medium was supplemented with 2 g/l tryptone and 1 g/l yeast extract
a pGS expresses glyoxylate reductase and isocitrate lyase, encoded by ghrA and aceA. pX1P carries (d)-xylulose-1 kinase, (d)-xylulose-1 aldolase and glycolaldehyde 
dehydrogenase, encoded by khkC, aldoB and aldA, respectively. pACT3 is the empty plasmid. Results are presented as mean ± STDV calculated from at least two 
replicate experiments
Strain name Additional deletions Plasmidsa Biomass Glycolic acid Acetate
Yield [g/g] Final conc. [g/l] Yield [g/g] Final conc. [g/l] Yield [g/g]
Pen1100 pACT3 0.10 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 4.20 ± 0.01 0.57 ± 0.00
Pen1042 pGS 0.16 ± 0.01 2.11 ± 0.49 0.29 ± 0.05 0.16 ± 0.23 0.02 ± 0.03
Pen1044 pGS + pX1P 0.13 ± 0.03 1.57 ± 0.24 0.24 ± 0.02 0.55 ± 0.11 0.08 ± 0.02
Pen1048 ΔxylB pX1P 0.09 ± 0.01 2.70 ± 0.16 0.45 ± 0.01 1.97 ± 0.31 0.33 ± 0.04
Pen905 ΔxylB pGS + pX1P 0.08 ± 0.01 2.24 ± 0.46 0.43 ± 0.05 1.34 ± 0.01 0.26 ± 0.02
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of the cells was extremely retarded resulting in incom-
plete expression of the GA pathways.
As shown in Fig.  2a, strain Pen905 first consumed all 
glucose in the medium before starting to utilize xylose. No 
growth was observed after glucose had been depleted and 
even after 100 h of cultivation the strain was only capable 
of consuming ~50  % of the xylose fraction. It was previ-
ously reported that stationary E. coli cells have a strongly 
decreased glucose uptake rate compared to exponentially 
growing cells [38, 39]. Our results suggest that xylose 
uptake is also reduced in the absence of growth. In an 
attempt to facilitate co-assimilation of glucose and xylose 
and/or to increase the xylose uptake rate during sta-
tionary phase, we replaced the natural promoter of the 
broad-range sugar permease, GalP [40, 41], by the strong 
constitutive promoter proD [22]. The resulting strain 
Pen979 continued to consume glucose and xylose sequen-
tially, but exhibited strongly improved sugar uptake rates 
and consumed nearly all xylose during the monitored incu-
bation period (Fig.  2b). As a consequence, the GA yield 
of strain Pen979 on total consumed sugar increased to 
0.63 g/g, which corresponds to a gain of ~70 % compared 
to strain Pen1042 which operates the glyoxylate pathway 
alone. The GA yield on the xylose fraction reached 0.75 g/g 
(Table 7). This value corresponds to 75 % of the theoretical 
maximum GA yield which can be achieved during simul-
taneous operation of the glyoxylate and X1P pathways, and 
is the highest GA yield reported so far.
In contrast to the Pereira et al. [14], who reported a GA 
yield of 0.63 g/g on pure xylose (Table 1), we chose to delete 
icd in our GA-producing strains, which resulted in the com-
plete inactivation of the oxidative Krebs cycle branch thus 
increasing the carbon flux into the GA-producing glyoxylate 
Table 7 Production of glycolic acid (GA) by different E. coli strains in medium containing glucose and xylose as carbon 
sources
All strains carried the deletions ∆aceB ∆glcDEFGB ∆gcl ∆edd-eda ΔiclR ΔarcA Δicd. Additional modifications are indicated in the table. Initial glucose and xylose 
concentrations were 2.5  and 5 g/l, respectively. The mineral medium was supplemented with 2 g/l tryptone and 1 g/l yeast extract
G glucose, X xylose, G + X total sugar
a  pGS expresses glyoxylate reductase and isocitrate lyase, encoded by ghrA and aceA. pX1P carries (d)-xylulose-1 kinase, (d)-xylulose-1 aldolase and glycolaldehyde 
dehydrogenase, encoded by khkC, aldoB and aldA, respectively. pACT3 is the empty plasmid
b  Results are presented as mean ± STDV calculated from at least two replicate experiments











Pen1042 pGS 0.30 ± 0.01 1.58 ± 0.11 0.37 ± 0.04 0.30 ± 0.05 0.47 ± 0.04
Pen1044 pGS + pX1P 0.26 ± 0.03 2.41 ± 0.64 0.42 ± 0.01 0.36 ± 0.09 0.49 ± 0.04
Pen1099 galPproD pGS + pX1P 0.24 ± 0.00 1.29 ± 0.00 0.33 ± 0.00 0.36 ± 0.02 0.35 ± 0.02
Pen905 ∆xylB pGS + pX1P 0.22 ± 0.02 1.98 ± 0.68 0.47 ± 0.12 0.37 ± 0.12 0.60 ± 0.11
Pen979 ∆xylB galPproD pGS + pX1P 0.23 ± 0.02 3.73 ± 0.16 0.63 ± 0.04 0.40 ± 0.01 0.75 ± 0.05
Fig. 2 Production of glycolic acid (GA) by optimized E. coli strains 
during growth on a synthetic mixture. a Strain Pen905 (∆aceB 
∆glcDEFGB ∆gcl ∆edd-eda ∆iclR ∆arcA ∆icd ∆xylB expressing pGS and 
pX1P). b Strain Pen979 (∆aceB ∆glcDEFGB ∆gcl ∆edd-eda ∆iclR ∆arcA 
∆icd ∆xylB galPproD expressing pGS and pX1P). Initial glucose and 
xylose concentrations were 2.5 and 5 g/l, respectively. Cultivation was 
carried out in shake flasks at 30 °C
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shunt. This metabolic engineering strategy proved very 
effective for increasing the GA yield, but also imposed the 
need for supplementing the cultivation medium with an 
amino acid source (yeast extract and tryptone in the present 
study) to enable growth of our strains. It remains to be eval-
uated whether the need for amino acid supplements can be 
tolerated in an industrial process.
Conclusions
We have demonstrated that the simultaneous operation 
of the synthetic X1P and the engineered glyoxylate path-
ways greatly increases the GA yield on xylose-rich sugar 
mixtures. These results confirm the strong stoichiometric 
advantage that is provided by the synthetic X1P pathway 
during GA production from xylose containing feed-
stocks. However, further strain optimization is required 
to improve growth and fermentation characteristics of 
the production strains. It can be expected that genomic 
integration of the genes that are currently expressed 
from the pGS and pX1P plasmids will alleviate a signifi-
cant metabolic burden, thus rendering growth of the cells 
more robust. In addition, our approach to enable GA 
production though the glyoxylate shunt by deleting icd 
strongly impaired growth of the cells. Thus, a more elab-
orate attenuation of Icd activity that maintains the ability 
of the cells to grow on mineral medium, e.g. by reduc-
ing its expression or by overexpressing aceK [12, 14], is 
clearly preferable when developing a strain for industrial 
applications. On the other hand, we reached a very high 
GA yield of 0.75 g/g during the utilization of the xylose 
fraction of the sugar mixture. This shows that prevent-
ing growth during xylose utilization may be a promising 
approach to make full use of the stoichiometric advan-
tage that is provided by the simultaneous operation of the 
glyoxylate and X1P pathways.
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